Generic name: mitomycin 5mg in 10mL
Dosage form: injection, powder, for solution
The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.
MUTAMYCIN should be given intravenously only, using care to avoid extravasation of the compound. If extravasation occurs, cellulitis, ulceration, and slough may result.
Each vial contains either mitomycin 5 mg and mannitol 10 mg, mitomycin 20 mg and mannitol 40 mg, or mitomycin 40 mg and mannitol 80 mg. To administer, add Sterile Water for Injection, 10 mL, 40 mL, or 80 mL respectively. Shake to dissolve. If product does not dissolve immediately, allow to stand at room temperature until solution is obtained.
After full hematological recovery (see guide to dosage adjustment) from any previous chemotherapy, the following dosage schedule may be used at 6 to 8 week intervals:
20 mg/m2 intravenously as a single dose via a functioning intravenous catheter.
Because of cumulative myelosuppression, patients should be fully reevaluated after each course of MUTAMYCIN, and the dose reduced if the patient has experienced any toxicities. Doses greater than 20 mg/m2 have not been shown to be more effective, and are more toxic than lower doses.
The following schedule is suggested as a guide to dosage adjustment:
|Nadir After Prior Dose|
|Leukocytes/mm3||Platelets/mm3||Percentage of Prior Dose to be Given|
No repeat dosage should be given until leukocyte count has returned to 4000/mm3 and a platelet count to 100,000/mm3.
When MUTAMYCIN is used in combination with other myelosuppressive agents, the doses should be adjusted accordingly. If the disease continues to progress after two courses of MUTAMYCIN, the drug should be stopped since chances of response are minimal.
- Unreconstituted MUTAMYCIN stored at room temperature is stable for the lot life indicated on the package. Avoid excessive heat (over 40° C, 104° F).
- Reconstituted with Sterile Water for Injection to a concentration of 0.5 mg per mL, MUTAMYCIN is stable for 14 days refrigerated or 7 days at room temperature.
- Diluted in various I.V. fluids at room temperature, to a concentration of 20 to 40 micrograms per mL:
I.V. Fluid Stability 5% Dextrose Injection 3 hours 0.9% Sodium Chloride Injection 12 hours Sodium Lactate Injection 24 hours
- The combination of MUTAMYCIN (5 mg to 15 mg) and heparin (1,000 units to 10,000 units) in 30 mL of 0.9% Sodium Chloride Injection is stable for 48 hours at room temperature.